Cardiff Medical Cannabis: Wales Prescribing Rules

Medical Cannabis in Wales: The Regulatory Framework

• Wales applies the same UK-wide Misuse of Drugs Regulations 2001 as England; only specialist consultants can prescribe cannabis medicines as Schedule 2 controlled drugs.
• NHS Wales does not routinely fund medical cannabis prescriptions beyond the specific NICE-approved indications such as Sativex for MS spasticity.
• The Welsh Government has expressed support for equitable patient access but has not introduced Wales-specific legislation expanding NHS cannabis prescribing.
• Cardiff is the principal hub for specialist private cannabis prescribing in Wales, with clinics also operating in Swansea and Newport.

Cardiff patients navigating medical cannabis prescribing operate within the UK regulatory framework, with the same rights and access routes available as patients in England.

Accessing a Prescription in Cardiff

• Self-referral to a private specialist clinic is the primary route; patients in Cardiff can attend in person or complete consultations via video call.
• Cardiff-based clinics typically assess patients with chronic pain, PTSD, epilepsy, anxiety disorders and neurological conditions.
• Medical records including GP summaries, diagnosis letters and evidence of previous treatment history must be provided at the initial consultation.
• Welsh Language services are available at some Cardiff clinics; patients who prefer to consult in Welsh should enquire before booking.

Cardiff’s growing clinic infrastructure means that Welsh patients no longer need to travel to London for a specialist cannabis consultation in most cases.

NHS Pilot Schemes and Welsh Government Policy

• Abertawe Bro Morgannwg University Health Board has piloted cannabis-based medicines for specific chronic pain patients; results informed subsequent policy discussions.
• Velindre Cancer Centre in Cardiff has been involved in cannabis-related palliative care research; oncology patients can enquire about research participation.
• Public Health Wales has published patient information on medical cannabis as part of its pain management resources, which can be downloaded from their website.
• The Welsh Assembly Health Committee has taken evidence on expanding access; patient advocacy groups including PLEA Wales have submitted formal representations.

While NHS-funded access in Wales remains limited, the policy landscape is shifting, and Cardiff patients benefit from active advocacy and growing political attention to the issue.

Pharmacy Access and Support in Cardiff

• Cardiff pharmacies holding Home Office Schedule 2 licences are limited; most Welsh patients rely on postal dispensing from national specialist pharmacies.
• Standard delivery to Cardiff postcodes is available from all major medical cannabis dispensing pharmacies, with turnaround of one to two working days.
• Patient support groups active in Wales include PLEA Cymru and the Wales chapter of the United Patients Alliance, which hold regular Cardiff events.
• Cardiff patients can contact their Assembly Member to raise concerns about access costs; several Senedd members have spoken publicly in support of expanded NHS prescribing.

Cardiff patients are part of an active and vocal community pushing for better access to medical cannabis in Wales; connecting with local advocacy groups can provide both practical support and a political voice.